Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.40 |
| ▸ | CA1 | P00915 | 6/20 | 0.40 |
| ▸ | CA2 | P00918 | 5/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | CBS | P35520 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14077932 | 0.83 | MAOA (0.45) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL12155186 | 0.83 | APLNR (0.43) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL18906911 | 0.82 | APLNR (0.37) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL20158289 | 0.82 | APLNR (0.37) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL18906915 | 0.82 | APLNR (0.37) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL24506767 | 0.82 | APLNR (0.42) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL857233 | 0.82 | APLNR (0.42) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL22030517 | 0.82 | CA12 (0.46) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL16789211 | 0.82 | APLNR (0.42) | APLNRMEN1GAAKMT2ACA12 | |
| SCHEMBL28124527 | 0.81 | MEN1 (0.37) | APLNRMEN1GAAKMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024255806-A1 | PREPARATION AND USE OF HYDROGEL | 粤港澳大湾区精准医学研究院(广州) | 2024-12-19 | — | — | WO | claimed |
| CN-119144151-A | Preparation of hydrogels and uses thereof | 粤港澳大湾区精准医学研究院(广州) | 2024-12-17 | — | — | CN | claimed |
| EP-4353704-A1 | METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS | King Faisal Specialist Hospital & Research Centre (SA) | 2024-04-17 | — | — | EP | claimed |
| US-20240116978-A1 | METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2024-04-11 | — | — | US | claimed |
| CN-113264967-B | Programmed death ligand-1 targeted compound and preparation method and application thereof | 江苏省原子医学研究所 | 2023-04-18 | — | — | CN | claimed |
| CN-115944727-A | Preparation method of magnetic reduced graphene oxide modified by fragmentation crystal mannose and lectin of antibacterial magnetic nanoenzyme | 宁波大学 | 2023-04-11 | — | — | CN | claimed |
| CN-111592530-B | Acldoxime-containing tacrine derivative selective butyrylcholinesterase inhibitor and preparation method and application thereof | 山东大学 | 2021-09-24 | — | — | CN | claimed |
| US-20210292275-A1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE (CZ) | 2021-09-23 | — | — | US | claimed |
| CN-113264967-A | Programmed death ligand-1 targeted compound and preparation method and application thereof | 江苏省原子医学研究所 | 2021-08-17 | — | — | CN | claimed |
| EP-3535238-B1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | VS CHEMICKO TECHNOLOGICKA V PRAZE (CZ) | 2021-04-21 | — | — | EP | claimed |
| WO-2021067387-A1 | ELABELA-DERIVED CONJUGATES AND METHODS OF USE | On Target Therapeutics, LLC (US) | 2021-04-08 | — | — | WO | claimed |
| CN-112375015-A | Preparation method of di-tert-butyloxycarbonylaminoacetic acid | 安徽昊帆生物有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-111592530-A | Acldoxime-containing tacrine derivative selective butyrylcholinesterase inhibitor and preparation method and application thereof | 山东大学 | 2020-08-28 | — | — | CN | claimed |
| CN-110698677-A | Giant surfactant high-temperature foam stabilizer, foaming liquid, and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-01-17 | — | — | CN | claimed |
| EP-0847241-B1 | INFLUENCING THE ACTIVITY OF PLANT GROWTH REGULATORS | PLANT RES INT BV (NL) | 2004-11-24 | — | — | EP | claimed |
| US-20030027722-A1 | Influencing the activity of plant growth regulators | PLANT RESEARCH INTERNATIONAL B.V. (NL) | 2003-02-06 | — | — | US | claimed |
| US-6242381-B1 | ADMINISTERING PLANT GROWTH REGULATORS | INSTITUUT VOOR AGROBIOLOGISCH EN BODEMVRUCHTBAARHEIDSONDERZOEK (NL) | 2001-06-05 | — | — | US | claimed |
| US-12637480-B2 | Heterocyclic compounds as sting modulators | BEONE MEDICINES I GMBH (CH) | 2026-05-26 | — | — | US | disclosed |
| EP-0438752-A1 | Monobactam hydrazides containing catechol sulfonic acid groups | E.R. SQUIBB & SONS, INC. (US) | 1991-07-31 | — | — | EP | disclosed |
| US-5030724-A | Monobactam hydrazides containing catechol sulfonic acid groups | E. R. SQUIBB & SONS, INC. (US) | 1991-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292275-A1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | LIPC, LYPLA2, PNLIP | APLNR 715/4885MEN1 2974/4885GAA 700/4885 |
| US-12637480-B2 | Heterocyclic compounds as sting modulators | STING1, IFNAR1, IRF3 | APLNR 406/4885MEN1 2147/4885GAA 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.